
    
      Although intravenous bolus infusion of terlipressin is the standard approach, continuous
      infusion of terlipressin is preferred in clinical practice. The present study is a pilot
      non-randomized controlled trial to explore the feasibility and safety of continuous infusion
      of terlipressin for the treatment of acute variceal bleeding in liver cirrhosis.
    
  